All Axxora Brands
Axxora Brands available in the selected country
Join Axxora
Corporate Profile
Sites
You are logged on as Guest.:  LoginRegister(Empty)
Change country
  United States
  • Home
  • Product Detail
New Products
Brands
Distributors
Support
About

Polyclonal Antibody to DR3 (NT)

 
PSC-1166-C020 20 µg 87.00 USD
 
PSC-1166-C100 100 µg 380.00 USD
 
Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand (CD95L) of the TNF family through their death domain containing receptors, TNFR-1 and Fas (CD95). A novel cell death receptor was identified by several groups independently and designated DR3, Wsl-1, Apo-3, TRAMP and LARD [1-5]. The ligand for this novel death receptor has been defined as TWEAK, also termed Apo3L.
more
DR3 is highly expressed in PBL and tissues enriched in lymphocytes including, thymus and spleen. Like TNFR1, DR3 induces apoptosis and NF-κB activation.
less
PRODUCT PROPERTIES
Alternative Name:TNFRSF 12
Immunogen:Synthetic peptide (PSC-1166P) corresponding to N-terminal (aa 25-40) human DR3 precusor [1,2].
Source:From rabbit.
Species reactivity:Human, Mouse
Applications:WB
Application Notes:Detects a band of ~59kDa by Western blot.
Positive Control:Jurkat whole cell lysate (Prod. No. PSC-1205) can be used as positive control.
Blocking Peptide:For Blocking Peptide see Prod. No. PSC-1166P.
Formulation:Liquid. 100µg purified rabbit IgG in 200µl PBS containing 0.02% sodium azide.
Long Term Storage:+4°C
Background / Technical Information:For the Original Manufacturer's data sheet please click here.

TECHNICAL DOCUMENTS

Print as PDF

RELATED PRODUCTS

Blocking Peptide for PAb to DR3 (NT...
Jurkat Whole Cell Lysate

PRODUCT SUPPORT

Technical Service
Bulk Quantity Quote
Customer Service

CATALOG SECTION

TWEAK & FN14 / DR3
TWEAK & FN14 / DR3
TWEAK & FN14 / DR3
TWEAK & FN14 / DR3

FIGURES

PSC-1166
PSC-1166
Figure: Western blot analysis of DR3 in Jurkat total cell lysate with anti-DR3 (NT) at 1:1000 dilution.

Product Literature References

LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing: G.R. Screaton, et al.; PNAS 94, 4615 (1997), Abstract; Full Text
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95): J.L. Bodmer, et al.; Immunity 6, 79 (1997), Abstract;
A death-domain-containing receptor that mediates apoptosis: J. Kitson, et al.; Nature 384, 372 (1996), Abstract;
Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B: S.A. Marsters, et al.; Curr. Biol. 6, 1669 (1996), Abstract;
Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95: A.M. Chinnaiyan, et al.; Science 274, 990 (1996), Abstract;
Bone Metabolism
Cancer
Cell Cycle
Cell Death / Apoptosis / Autophagy / Necrosis
Chemokines & Cytokines
Cytoskeleton
DNA & Protein Labeling
DNA Regulation / Transcription
Drug Discovery
Dyes / Stains / Fluorescent Probes
Epigenetics
Immunology
Inflammation
Molecular Biology / Genomics
Natural Products / Antibiotics
Neurobiology
Nitric Oxide Pathway
Obesity & Adipokines
Oxidative Stress
Proteasome & Related Complexes
Protein Expression / Modification
Signal Transduction
Stress & Heat Shock Proteins
Ubiquitin & Ubl Signaling
Other Products
another CS2 website
©2019 Axxora, LLC.,
  • Privacy
  • Disclaimer
  • Terms
  • Legal
  • Sitemap
  • Feedback